TNFRSF8 and Hodgkins lymphoma: Recently, Ramos and colleagues have conducted two phase I/II clinical trials where autologous CD30 CAR Ts were administered to patients with r/r Hodgkin lymphoma after lymphodepletion with fludarabine in combination with either bendamustine or cyclophosphamide (131).